参麦注射液联合多巴胺治疗64例慢性肺心病疗效观察

目的：观察参麦注射液联合多巴胺治疗慢性肺心病的临床疗效,为中西医结合治疗慢性肺心病的提供临床依据。方法：回顾性分析我院2010年12月-2013年12月间收治的128例慢性肺心病患者,随机将其分为观察组和对照组,各64例。对照组单纯给予多巴胺20mL加入5%葡萄糖液250mL静脉滴注,观察组给予参麦注射液40∽60mL联合多巴胺20mL加入5%葡萄糖液250mL中静脉滴注,观察对比两组的疗效。结果：参麦注射液联合多巴胺治疗慢性肺心病的临床疗效优于单纯西药治疗,差异有统计学意义（P〈0.05）。结论：参麦注射液联合多巴胺治疗慢性肺心病,方法简单可行,临床疗效可靠确切,值得推广使用。

Effective observation on treating 64 cases of chronic cardiopulmonary disease with the Shenmai injection plus dopamine

Objective： To observe clinical efficacy of the Shenmai injection plus dopamine on chronic cardiopulmonary disease. Methods： 128 patients were randomly divided into the observation group and the control group by the retrospective analysis from Dec. 2010 to Dec. 2013. 64 cases in the observation group were given 20 mL dopamine in 250mL 5% glucose injection. 64 cases in another group were given 40∽60mL of the Shenmai injection plus 20 mL of dopamine in 250mL 5% glucose injection. Clinical efficacy in two groups was compared. Results： The efficacy in the control group was better than that in the observation group. The difference was statistically significant （P〈0.05）. Conclusion： The Shenmai injection shows good clinical effects, and is easy to operate, and is worthy of promotion.